About ERIX
EiRx Therapeutics is a specialist provider of pre-clinical therapeutics to the pharmaceutical industry. Our unique scientific expertise and knowledge in the field of Apoptosis provide a sound base to discover and develop new medicines that will safely and selectively repair this natural process in disease. The potential benefits from these new medicines are enormous, since as many as 70% of all human disease have some defect in the control of Apoptosis.
Apoptosis - the biological process that determines whether cells in our bodies live or die...
http://www.eirx.com/index.html

Purchased some of these on the strength of the PROGRESS UPDATE looks promising.
http://moneyam.uk-wire.com/cgi-bin/articles/200603200701130254A.html

ERX interview with John Pool
http://www.wallstreetreporter.com/interview.php?id=18589&player=real
Latest News
CANCER COLLABORATION WITH BIOMERIEUX SA
http://moneyam.uk-wire.com/cgi-bin/articles/200607120700230534G.html
Biomerieux Web Site
http://www.biomerieux.com/servlet/srt/bio/portail/home
ABOUT ERX Focus Of The Month
http://www.billamag.net/focus-document-text.asp?FocusTextID=1
ERX pdf filehttp://www.eirx.com/eirx_heading_images/Yokohama2005.pdf
19/09/2006 A 50% reduction in breast tumour volume size seen with Eirx lead molecule in animal studies
http://moneyam.uk-wire.com/cgi-bin/articles/200609190700171175J.html

Past and present collaborative partners include:

* bioMieux SA
* Almac Diagnostics Ltd
* Merck & Co, Ltd
* Biofocus plc
* MGI Pharmaceuticals, Inc
* OSI Pharmaceuticals, Inc
* Sareum plc
* Regen Therapeutics plc
* SR Pharma plc

next week is going to more than exciteing

PH let it just happen we already hold and constant long winded ramping is still driving people away not into ERX.
The sheer number of BB's makes anything said to be unreliable even without the drivel and personal conflicts.

NOTE JOHNSON AND JOHNSON HAS BEEN VISITING THE BB. WE MAY HAVE BAGGED A BIGGY

HERE IS THERE WEBSITE http://www.investor.jnj.com/calendar.cfm

J&J IP ADDRESS 148.177.129.213

VISITOR ANALYSIS
Referring Link No referring link
Host Name proxy2.be.jnj.com
IP Address 148.177.129.213
Country United States
Region New Jersey
City Raritan
ISP Johnson & Johnson
Returning Visits 18
Visit Length 1 min 51 secs
VISITOR SYSTEM SPECS
Browser MSIE 6.0
Operating System Windows 2000
Resolution Unknown
java script Disabled

Navigation Path

they vistited the AD fvn thread, it has an IP checker..

why are J&J from the USA visiting a UK BB..

buy as many as you can, they have visited the thread 18 times today and they visited yesterday as well, which is interesting as the sp rose 35% yesterday

yes I saw, looks like J&J def takeing a look for some reason. Is this part of the big plan.

Smith and nephew checking us out now also.. looks very good

J&J are back, go look on competitor thread and click on view my stats. they are watching the SP of erx

J&J are back, go look on competitor thread and click on view my stats. they are watching the SP of erx

VISITOR ANALYSIS
Referring Link No referring link
Host Name clsm-002399.iahs.abdn.ac.uk
IP Address 139.133.130.2
Country United Kingdom
Region -
City -
ISP University Of Aberdeen
Returning Visits 0
Visit Length 0 seconds
VISITOR SYSTEM SPECS
Browser MSIE 6.0
Operating System Windows XP
Resolution Unknown
java script Disabled


ISP University Of Aberdeen

OK LADS SOMETHING DEF UP, ISP University Of Aberdeen

14mil buy gone through

VISITOR ANALYSIS
Referring Link No referring link
Host Name
IP Address 145.8.174.124
Country Netherlands
Region -
City -
ISP Hoogovens Ijmuiden Bv
Returning Visits 9
Visit Length 0 seconds
VISITOR SYSTEM SPECS
Browser MSIE 7.0
Operating System Windows XP
Resolution Unknown
java script Disabled


Hungry Wolf - 29 Jan'07 - 15:07 - 4974 of 4975 (premium)


OD. Just wanted some action and move things along. Always hold a nice bunch just in case. I might go and cancel in a minute.

bluedoolhine - 29 Jan'07 - 15:07 - 4975 of 4975 edit


PDF] Merger Decision IV/M.578 of 11.04.1995File Format: PDF/Adobe Acrobat - View as HTML
will be an existing subsidiary of Hoogovens, Pharnaces IJmuiden B.V., which will be renamed. ODS. To this company will be transferred the shareholding of ...
ec.europa.eu/comm/competition/mergers/cases/decisions/m578_en.pdf -

imoressive, the worm is now turning

UNIVERSITY OF ABERDEEN ARE WATCHING THE SHARE OVER ON AD FVN (the darkside). YESTERDAY THEY APPEARED AND A 14MIL BUY CAME IN..

PH - Love the way you make something out of nothing.

Because an IP address can be traced back to the originating sender doesn't really tell us anything about the identity of the sender or their intentions, especially when the sender is an institutuion. Did you not consider that the IP addresses you say were sent from J&J and S&N may simply be from employees of these companies using the company facilities to browse the web? Even if one of these employees were interested in EiRX this doesn't mean that J&J or S&N are.

As for the University of Aberdeen, it was probably just a student visiting the bulletin boards. I wouldn't get too excited about that.

Have to admire your enthusiasm, but please for the sake of all other serious investors can you tone down your inane rants and claims a little. Ta.

CrouchingTiger - 31 Jan'07 - 00:17 - 5244 of 5253


An offer has been made for ERX by a major pharm, stick with it

Total Voting Rights

http://moneyam.uk-wire.com/cgi-bin/articles/200701311121474445Q.html

PH you have got to be the worst ramper in the world!!!!!!! Don't you think that if an approach was made there would not be an announcement!!!

PH : GO AWAY AND VISIT THE TOILET AS YOU ARE OBVIOUSLY FULL OF SH:::T

PH, The only way that you will know of an offer for the company before the MM's, is if it is you that is going to buy it. So please enlighten us, as to how much you are paying, then we can all benefit by buying in before you formally make your offer to ERX.

it was not PH who mentioned it, someone called C.Tiger said offer on table, anyone see C4, talked about P53 and people going to china to receive the treatment before its even passed testing, and results are very positive. We could see serious action tomorrow

very quiet considering the agm is tomorrow